Dr. Scholl’s Custom Fit Orthotic Inserts, CF 330
The only insoles with 5 in 1 clinically proven pain relief from daily activities, including lower back pain, knee pain, heel pain and plantar fasciitis and general foot pain as well as tired, achy feet and legs
Provides immediate, all-day lower body pain relief from being on your feet. Protects joints from daily shock and impact and helps prevent pain from coming back.
Offers 3D heel, arch and ball of foot support. It ensures your toes have ample space and don’t become overcrowded in your shoe. Also great for wide feet.
Amazon.com Price: $49.96 (as of 10/04/2023 02:09 PST- Details)
Dr. Scholl’s Foot Mapping Technology provides a custom fit orthotic that will cradle and flex with your foot providing unparalleled comfort and support all daylong. Using the revolutionary pressure measurement system to recommend the perfect orthotic for you, you’ll get the best fit possible for your stance. This orthotic, tested by podiatrists, offers stabilization of your arch and fits in most shoes and for feet identified as needing size CF 330.Features & Benefits:Foot mapping technology100% Customer satisfactionCradle flex arch supportExtra support layers designed for customized cushioning and comfortDurable top cloth
The only insoles with 5 in 1 clinically proven pain relief from daily activities, including lower back pain, knee pain, heel pain and plantar fasciitis and general foot pain as well as tired, achy feet and legs
Provides immediate, all-day lower body pain relief from being on your feet. Protects joints from daily shock and impact and helps prevent pain from coming back.
Offers 3D heel, arch and ball of foot support. It ensures your toes have ample space and don’t become overcrowded in your shoe. Also great for wide feet.
Best for shoes with non-removable factory insoles, or tighter fitting shoes like dress shoes or flats. Offers flexibility to move from shoe to shoe. No trimming required!
Specification: Dr. Scholl’s Custom Fit Orthotic Inserts, CF 330
|
There are no reviews yet.